Titelia

Holdings of DIADEMA PARTNERS LP

75 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 51.7 % of the equity sleeve

Sector breakdown

  • Health care 20.3 %
  • Materials 3.5 %
  • Unattributed 76.1 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 93.7 %
  • FR 4.9 %
  • GB 1.2 %
  • DK 0.3 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US69195.2M $93.72 %
FR210.2M $4.88 %
GB32.4M $1.15 %
DK1520.7K $0.25 %

Positions

CompanySharesValueWeight
Viking Therapeutics Inc 525,18117.1M $
United Therapeutics Corp 27,30316.2M $
Johnson & Johnson 53,77113.1M $
Cogent Biosciences Inc 322,76412.4M $
Terns Pharmaceuticals Inc 181,7529.6M $
BioMarin Pharmaceutical Inc 148,2298.4M $
Abivax SA 75,9448.2M $
Revolution Medicines Inc 80,8727.9M $
Kodiak Sciences Inc 192,9627.4M $
Incyte Corp 78,0297.3M $
TG Therapeutics Inc 206,9286.9M $
Bridgebio Pharma Inc 85,3116.3M $
Immunocore Holdings PLC 193,1895.8M $
Eli Lilly & Co 6,0005.5M $
AbbVie Inc 24,0585.2M $
Arcus Biosciences Inc 238,1425.1M $
Corbus Pharmaceuticals Holdings Inc 439,9574.1M $
Corvus Pharmaceuticals Inc 244,8113.6M $
Zymeworks Inc 142,1323.6M $
Structure Therapeutics Inc 72,2343.5M $
Monte Rosa Therapeutics Inc 187,3073.1M $
Tenax Therapeutics Inc 179,7382.9M $
Harmony Biosciences Holdings Inc 92,8642.6M $
Capricor Therapeutics Inc 78,8512.4M $
EyePoint Inc 178,5452.3M $
Bicycle Therapeutics PLC 476,4242.2M $
Indivior Pharmaceuticals Inc 71,3762.2M $
Climb Bio Inc 286,1262M $
Inventiva SACA 352,3991.9M $
Shattuck Labs Inc 293,6641.9M $
Tarsus Pharmaceuticals Inc 25,9421.8M $
MacroGenics Inc 600,0001.7M $
Vertex Pharmaceuticals Inc 3,8401.7M $
Voyager Therapeutics Inc 423,6421.6M $
Vaxcyte Inc 25,0711.5M $
Relmada Therapeutics Inc 200,8421.4M $
BioAge Labs Inc 60,0001M $
INOVIO PHARMACEUTICALS INC 562,665979K $
Aytu BioPharma Inc 353,077963.9K $
Equillium Inc 433,844867.7K $
Dianthus Therapeutics Inc 10,000839.2K $
Enanta Pharmaceuticals Inc 64,952820.3K $
Replimune Group Inc 100,660770K $
Xeris Biopharma Holdings Inc 132,746769.9K $
Larimar Therapeutics Inc 166,637749.9K $
Annexon Inc 132,916736.4K $
Ultragenyx Pharmaceutical Inc 35,144736.3K $
Mineralys Therapeutics Inc 26,347713.7K $
Unicycive Therapeutics Inc 106,083698K $
SPRUCE BIOSCIENCES INC 10,000653.5K $
Phathom Pharmaceuticals Inc 54,650607.2K $
Celcuity Inc 5,314606.5K $
Novo Nordisk A/S 14,577520.7K $
PELTHOS THERAPEUTICS INC 24,773520.5K $
MannKind Corp 186,603457.2K $
Maze Therapeutics Inc 15,000447.8K $
Corcept Therapeutics Inc 10,000403.1K $
Lipocine Inc 50,000399.5K $
Foghorn Therapeutics Inc 79,944382.1K $
Ocugen Inc 200,000362K $
PepGen Inc 150,925267.1K $
Trevi Therapeutics Inc 21,663258.4K $
Precigen Inc 55,293214K $
Upstream Bio Inc 21,609194.5K $
Compass Pathways plc 31,885176.3K $
Passage Bio Inc 19,530153.3K $
TALPHERA INC 153,563114.7K $
Rocket Pharmaceuticals Inc 30,579109.5K $
Monopar Therapeutics Inc 1,63089.3K $
VISTAGEN THERAPEUTICS INC 105,42860.3K $
Atrium Therapeutics Inc 2,51233.6K $
CUE BIOPHARMA INC 131,99730.3K $
PURETECH HEALTH PLC 7,92411.3K $
Enliven Therapeutics Inc 2459.6K $
Septerna Inc 2024.9K $